Skip to main content
. 2021 Jul 3;18(5):630–638. doi: 10.1177/17407745211028898

Figure 3.

Figure 3.

The minimum enrollment size required for an individually randomized vaccine efficacy trial to achieve at least 90% probability of success for different target numbers of events and numbers of sites. Sites were ranked by average site-level incidence of infection across all simulated outbreaks in 1 year (2017) with enrollment proportional to average site-level incidence of infection.